Chlor-Mes Interactions
There are 523 drugs known to interact with Chlor-Mes (chlorpheniramine / methscopolamine / phenylephrine), along with 25 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 35 are major, 470 are moderate, and 18 are minor.
- View all 523 medications that may interact with Chlor-Mes
- View Chlor-Mes alcohol/food interactions (2)
- View Chlor-Mes disease interactions (25)
Most frequently checked interactions
View interaction reports for Chlor-Mes (chlorpheniramine / methscopolamine / phenylephrine) and the medicines listed below.
- Dallergy (chlorcyclizine / phenylephrine)
- levothyroxine
- orlistat
- triamcinolone nasal
- TriCor (fenofibrate)
Chlor-Mes alcohol/food interactions
There are 2 alcohol/food interactions with Chlor-Mes (chlorpheniramine / methscopolamine / phenylephrine).
Chlor-Mes disease interactions
There are 25 disease interactions with Chlor-Mes (chlorpheniramine / methscopolamine / phenylephrine) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- cardiovascular disease
- cardiac disease
- tachycardia
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- BPH
- diabetes
- glaucoma
- hypertension
- hyperthyroidism
- diarrhea
- fever
Report options
More about Chlor-Mes (chlorpheniramine / methscopolamine / phenylephrine)
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
